核与辐射事故应急药物储备研究进展  

Research progress in emergency drug stockpile for nuclear and radiological accidents

作　　者：崔凤梅 薛惠元 宗旭敏 高锦 孙亮[1] 万骏[1] 陈娜[1] 涂彧[1] Cui Fengmei;Xue Huiyuan;Zong Xumin;Gao Jin;Sun Liang;Wan Jun;Chen Na;Tu Yu(State Key Laboratory of Radiation Medicine and Protection,School of Radiation Medicine and Protection,Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions,Soochow University,Suzhou 215123,China)

机构地区：[1]苏州大学苏州医学院放射医学与防护学院,省部共建放射医学与辐射防护国家重点实验室江苏省高校放射医学协同创新中心,苏州215123

出　　处：《中华放射医学与防护杂志》2023年第5期393-399,共7页Chinese Journal of Radiological Medicine and Protection

摘　　要：在当前国际形势下,存在核战争和核恐怖发生的可能性,核与辐射事故应急不可懈怠。世界卫生组织(WHO)于2023年1月27日发布出版物,更新了应对辐射和核紧急情况建议储备的药物清单,这是自2007年以来的首次更新。出版物里建议的药物储备清单,包括防止或减少辐射影响的药物,以及在受照后用于治疗损伤的药物。围绕该药物清单,从核与辐射事故应急、应急药物储备概况、一些国家的药物储备和当前的思考等几个方面进行综述,以期为我国核与辐射事故应急医学救援提供参考。In the current international situation,there is the possibility of nuclear war and nuclear terrorism.The nuclear and radiological emergency in the event of an accident should be enhanced.The World Health Organization(WHO)issued a publication on January 27,2023,updating the list of drugs recommended for stockpiling in response to radiation and nuclear emergencies,which was the first update since 2007.The list of recommended drug stocks in the publication includes drugs to prevent or reduce the effects of radiation,as well as drugs used to treat injuries after exposure.Based on the list of drugs,this article reviews the emergency response to nuclear and radiological accidents,the general situation of emergency drug stockpiles,drug reserves in some countries,and current considerations,with a view to providing references for emergency medical rescue in nuclear and radiological accidents in China.

关 键 词：核与辐射应急 急性放射综合征 医学救援 药物储备 

分 类 号：R95[医药卫生—药学]